Physician profile
Daniel Duran
NPI 1376030395
$553.51
in general payments reported to CMS, 2019-2025
9 companies · $210 in 2025
The $210 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.32 · 2021: $15.82 · 2022: $23.44 · 2023: $15.28 · 2024: $267 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $491.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alon Medical Technology | $151.29 | 2024 | |
| Spineology INC. | $126.02 | 2025 | |
| Stryker Corporation | $74.47 | 2024 | N/A |
| Medtronic, INC. | $72.36 | 2021-2024 | Kyphon Express II Kyphopak Tray, Synchromedii, Stealthstation S8 Platform |
| Providence Medical Technology, INC. | $32.58 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $28.95 | 2025 | |
| Si-Bone, INC. | $23.44 | 2022 | |
| Csl Behring | $22.32 | 2019 | |
| Integra Lifesciences Corporation | $22.08 | 2025 | Codman Hakim, Cusa Clarity, Codman Certas |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Duran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.